Skip to main content
Close
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > Prizes > Prize Recipients > Michaela Gack

Michaela Gack

2017 Vilcek Prize for Creative Promise in Biomedical Science

Location

Chicago, IL

Title

Associate professor, University of Chicago

Area(s) of Research

Immunology; infectious diseases; virology

Education

Harvard Medical School; Friedrich Alexander University in Erlangen-Nuremberg

Country of Birth

Germany

Tags
biomedical science germany immunology infectious diseases microbiology molecular biology University of Chicago virology women in science women in stem
Share this page
Twitter Facebook LinkedIn

Early success is a recurring theme in Michaela Gack’s scientific career. Gack’s ambition has fueled her meteoric rise through the ranks of molecular biology, and her work has unraveled the intricacies of how viruses evade the human immune system.

Raised in a small town in the German state of Bavaria, Gack became enamored with human biology as an undergraduate student at Friedrich Alexander University in Erlangen-Nuremberg. In 2005, she began PhD studies in the lab of molecular biologist Jae Jung at a graduate training program between her university and Harvard Medical School. There, Gack identified a novel molecular mechanism through which a protein in human cells called RIG-I mediates defense against viruses. “RIG-I essentially alerts the immune system to the presence of viruses and sets off an immune response, but many aspects of its mechanism of activation were unclear,” she says.

Michaela Gack is seen looking into a microscope through a gap made by the shelves in the lab.

She found that an enzyme called TRIM25 activates RIG-I by tagging it with a protein called ubiquitin. Once tagged, RIG-I triggers the production of antiviral defense molecules known as interferons. Gack’s work, published in Nature, surprisingly revealed that avian, swine, and human flu viruses block TRIM25 to evade immune defense by RIG-I, unraveling a molecular target for the design of antiviral drugs and vaccines.

The discovery promptly earned her wide acclaim and a faculty appointment at Harvard Medical School, where she rose to an associate professorship in just six years. In 2015, she accepted an associate professorship at the University of Chicago.

Michaela Gack stands in the center of the image with her arms folded, surrounded by lab equipment.

Gack’s work has also shed light on the mechanisms through which mosquito-borne viruses evade the human immune response. She has provided a framework for rational vaccine design against emerging infectious diseases. Her goal is to continue to unravel molecular mechanisms that might someday yield antiviral vaccines and drugs not only for emerging and re-emerging viruses but also tumor-inducing viruses, such as certain herpesviruses and human papillomaviruses.

 

Awards and Accomplishments

  • “Top 10 Under 40” list in Biopharma and Business, US (2017)
  • John and Virginia Kaneb Award (2015)
  • Merck Irving S. Sigal Memorial Award
  • American Society for Microbiology (2014)
  • “Top 40 Under 40” Scientist, Germany (2013–2015)
  • Ann Palmenberg Junior Investigator Award (2013)
  • Junior Investigator Award, European Society for Virology (2013)
  • The Christina Fleischmann Award to Young Women Investigators (2013)
  • William F. Milton Fund Award (2012)
  • Selected as one of “100 Women of Tomorrow” — President of Germany (2011)
  • Otto Westphal Prize, German Society for Immunology (2009)
  • Robert Koch Postdoctoral Prize (2009)
  • GE & Science Prize for Young Life Scientists (2009)
  • Millipore Young Cell Signaler Award (2007)
  • Karl von Frisch Prize (1998)
Tags
biomedical science germany immunology infectious diseases microbiology molecular biology University of Chicago virology women in science women in stem

Jury Members

2017 Vilcek Prize for Creative Promise in Biomedical Science

Iannis Aifantis

Professor and Chair of Pathology, New York University School of Medicine

Heran Darwin

Professor of Microbiology, New York University School of Medicine

Laurie Dempsey

Senior Editor, Nature Immunology, Nature Publishing Group

Yibin Kang

Warner-Lambert Parke-Davis Professor of Molecular Biology, Princeton University

Peter Palese

Horace W. Goldsmith Professor and Chair of Microbiology, Professor of Medicine, Icahn School of Medicine at Mount Sinai

Leslie Vosshall

Robin Chemers Neustein Professor, The Rockefeller University

Jedd Wolchok

Lloyd J. Old Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center
Share this page
Twitter Facebook LinkedIn

Related Prize Recipients

Silvi Rouskin

Silvi Rouskin receives the Vilcek Prize for Creative Promise in Biomedical Science for developing methods to unravel the shapes of RNA molecules inside cells and aiding the potential development of RNA-based therapeutics.
Portrait of Silvi Rouskin

Ruth Lehmann

Ruth Lehmann receives the Vilcek Prize in Biomedical Science for unraveling the molecular basis by which germ cells, which give rise to sperm and egg cells, are formed.
Portrait of Ruth Lehmann

Pardis Sabeti

Pardis Sabeti receives the Vilcek Prize for Creative Promise in Biomedical Science for developing cutting-edge genome sequencing and bioinformatics tools to trace the origin and spread of deadly infectious diseases, including Ebola and Lassa fever, among others.
Pardis Sabeti

You may also be interested in

March 29, 2022

Katalin Karikó: The sacrifices and successes of immigrant scientists

Amid multiple awards for the development of mRNA vaccines, Hungarian biochemist Katalin Karikó insists that her greatest success has been being able to show up every day for a career she is passionate about.
Katalin Karikó standing in the woods in a beige coat with fur trim.
February 22, 2021

Ruth Lehmann: “There’s always another question… there’s always more to find out”

Molecular and cellular biologist Ruth Lehmann receives the Vilcek Prize in Biomedical Science for her research and leadership in the field.
A portrait of Ruth Lehmann in a black blazer as she stands on a bridge over the Charles River.
October 5, 2022

Science Crossing Borders: The Vilcek Science Symposium

Led by Creative Promise Prizewinner Jeanne T. Paz, the Vilcek Science Symposium brings immigrant scientists together for a two-day conference at the Gladstone Institutes.
Jeanne Paz stands smiling in her lab coat in front of a building at the Gladstone Institute.

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2023   Vilcek Foundation